Navigation Links
Three Studies by Independent Scientists Highlighting Pressure Cycling Technology (PCT) to be Presented this Week at the British Mass Spectrometry Society's 29th Annual Meeting
Date:9/10/2007

WEST BRIDGEWATER, Mass., Sept. 10 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) ("PBI") today announced that data highlighting the advantages of pressure cycling technology (PCT) in studies to (1) better understand the events surrounding stroke, (2) detect biomarkers of colon cancer, and (3) detect proteins associated with embryo viability are to be presented this week in three presentations at the 29th Annual Meeting of the British Mass Spectrometry Society (BMSS). The data were generated by scientists at The New York University (NYU) School of Medicine and the Brooklyn Hospital Center. The presentations will be delivered by Dr. Paul Pevsner, M.D. of the NYU School of Medicine.

Approximately three hundred scientists from around the world are expected to attend the BMSS meeting, where mass spectrometry-related data generated in many key areas of human, animal, and plant research will be showcased. The meeting is being held at the Heriot-Watt University in Edinburgh Scotland.

Dr. Paul H. Pevsner, senior author of the research studies and a scientific investigator at the NYU School of Medicine, said: "Our research program is focused in three areas. First, we are investigating the cascade of events that occurs immediately following a stroke, in an effort to develop successful post-stroke therapeutics. Second, we are attempting to discover new biomarkers of colon cancer, in an effort to develop better surgical aids and diagnostics. Third, we are trying to identify proteins associated with embryo viability from growth media fluid, in an effort to develop better in- vitro fertilization techniques."

Dr. Pevsner continued: "In all cases, we were extremely pleased that PCT could successf
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. The TripleMaster PCR System for three different amplifications
2. Cloning Based on Efficient Three-Fragment Assembly DNA Ligation
3. Three Micron TSK-GEL ODS-100V Columns for High Throughput LCMS
4. Three finalists named for UW-Madison CIO
5. Three state businesses receive technology grants
6. Leading cancer institute to install three TomoTherapy systems
7. Waukesha considers wireless bids from three firms
8. Computerworld top 100 includes three Wisconsin CIOs
9. 30 days to success: Three simple steps to create your own international startup
10. Three firms get state tech development grants
11. Three more Wisconsin firms to present at venture forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Contract Research Organization XenoTech, LLC , a ... new 41,500 ft2 facility. The planned move will double ... W. 116th St. in Lenexa, KS. The new facility, ... space, will remain in the Kansas City metro area, just ... twenty years ago. Remaining in the Kansas City area ...
(Date:4/21/2015)... April 21, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... multi-arm Phase 1 study of MM-141, a bispecific antibody ... an oral session by Dr. Mansoor Saleh , ... Annual Meeting in Philadelphia, PA. ... as a monotherapy and in combination with everolimus or ...
(Date:4/21/2015)... 21, 2015  Cryoport, Inc. (OTCBB: CYRX) ... logistics solutions for the life sciences industry, ... lines, clinical research organizations, vaccine manufacturers and ... Mark W. Sawicki , Chief Commercial Officer, ... Summit in San Francisco, CA ...
(Date:4/21/2015)... April 21, 2015 PRC Clinical, ... and exhibit at the ACRP 2015 Global Conference and ... Utah. The Association of Clinical Research Professionals (ACRP) Global ... conference solely focused on the conduct of clinical trials. ... development, and widely recognized industry certifications. , The ...
Breaking Biology Technology:XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014 2XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 3PRC Clinical Sponsors The ACRP 2015 Global Conference And Meets Biotech Companies in the Salt Lake City Area. 2
... Pharma, Inc., a privately-,held, specialty pharmaceutical company, announced ... A financing, which included investors Domain Associates,Latterell Venture ... is committed to the development of prescription,products based ... the unmet,needs of patients and their caregivers. Meritage ...
... Gen-Probe Incorporated,(Nasdaq: GPRO ) announced today that the ... Annual Growth Stock on Wednesday, June 18, 2008 at,approximately ... be,webcast live and may be accessed through a link ... http://www.gen-probe.com . The webcast will be,available for 30 days ...
... - Potential to combine compounds with multiple new and existing ... with activity ... against drug-resistant organisms -, SAN DIEGO and LONDON, June ... have entered into a,worldwide strategic alliance for the discovery, development ...
Cached Biology Technology:Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing 2Gen-Probe to Webcast Presentation at the William Blair & Company 28th Annual Growth Stock Conference 2GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 2GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 3GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 4GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 5
(Date:4/13/2015)... 13, 2015  higi, a leading cloud-based consumer engagement ... fully engage with their communities around health and wellness, ... and secure API.  ... accessible, affordable, and convenient vehicle to receive validated health ... The API will allow higi,s trusted partners, ...
(Date:4/9/2015)... Calif. , April 9, 2015 Synaptics ... interface solutions, announced today that it will report financial ... Thursday, April 23, 2015, after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
(Date:4/6/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market, announced today ... MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM FOR ... introduces a new revolutionary method and system to ... of miniature antenna modules for multiple purposes including ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... Extra genomes appear, on average, to offer no benefit or ... the origin of new species, say scientists from Indiana University ... of the National Academy of Sciences . Plant biologists ... chromosome sets -- was a gateway to speciation. But the ...
... Folsom, CA August 11, 2009 On Monday, August ... 90th Annual Pacific Division Meeting of the AAAS in San ... science communication from some of the brightest minds in the ... Part of the Job: Communicating Science to the Public. (Online ...
... at Oregon State University have discovered that the circadian rhythms ... more susceptible to pesticides at some times of the day ... it may be possible to tap into this genetic characteristic, ... to a specific pesticide, and use that information to increase ...
Cached Biology News:Genome duplication responsible for more plant species than previously thought 2Genome duplication responsible for more plant species than previously thought 3Science communication to take the stage at annual AAAS meeting in San Francisco 2Biological clocks of insects could lead to more effective pest control 2Biological clocks of insects could lead to more effective pest control 3
Luminometers...
...
Cell Lysis Buffer is used to lyse cells under nondenaturing conditions....
LECHNER AND LaVECK MEDIUMfor the clonal growth of normal human bronchial and other epithelial cells. Requires additives. With glutamine.Recommended storage condition:oC to 8oCIntended use(s):research...
Biology Products: